SNHG15 and prostate cancer: The expression of SNHG15 was typically increased in multiple tumors, including lung carcinoma (LC), esophageal cancer, gastric cancer (GC), colorectal cancer (CRC), hepatocellular carcinoma (HCC), PC, kidney cancer, prostate cancer, breast carcinoma (BC), cervical and ovarian cancers (CC, OC), osteosarcoma (OS), oral cancer, glioma, and bladder cancer (Table 1).